# Xiidra

NDC: 0078-0911
Generic name: Lifitegrast
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION/ DROPS
Routes: OPHTHALMIC
Marketing started: 20160711

FDA application: NDA208073

## Active ingredients

- LIFITEGRAST: 50 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-0911"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-0911
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8589d376-ac10-4ddb-9c53-2e0c8d5675c4